Metastatic Cutaneous Melanoma

Oncology

11 drugs in development·4 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(11)

Drug	Company
Dacarbazine	Filana Therapeutics Inc. (FLNA)
Dacarbazine	ENANTA PHARMACEUTICALS INC (ENTA)
IMA203	PTC THERAPEUTICS, INC. (PTCT)
IMA203	ENANTA PHARMACEUTICALS INC (ENTA)
IMA203	Merus N.V. (MRUS)
IMA203	Filana Therapeutics Inc. (FLNA)
lifileucel	Merus N.V. (MRUS)
lifileucel	Filana Therapeutics Inc. (FLNA)
lifileucel	PTC THERAPEUTICS, INC. (PTCT)
lifileucel	ENANTA PHARMACEUTICALS INC (ENTA)
temozolomide	ENANTA PHARMACEUTICALS INC (ENTA)

BioSniper tracks 11 drugs in development for Metastatic Cutaneous Melanoma across 4 companies.

There are 2 clinical trials targeting Metastatic Cutaneous Melanoma tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.